Advisory Board
ITSCHAK SHREM
Chairman
Mr. Shrem has served as our President since January 2022 and on our Board of Directors since August 2020. Mr. Shrem has our Chairman between August 2020 and January 2021 and brings more than 40 years of experience in financial markets and venture capital. In 1991, Mr. Shrem founded Dovrat Shrem Ltd., an investment banking, management and technology company. Prior to that, he spent 15 years at Clal Israel Ltd., where he served in various capacities, including chief operating officer, and was responsible for capital markets and insurance businesses. In 1993, Mr. Shrem founded Pitango Venture Capital Fund (formerly, Polaris) and served as a partner of Pitango Funds I, II and III. He has been the Managing Director of Yaad Consulting 1995 Ltd. since 1995.
Mr. Shrem currently serves on the board of directors of Rail Visions Ltd. and has previously served on the board of Tel-Aviv Sourasky Medical Center, the Weizman Institute Eden Spring Ltd., Nano Dimension Ltd., Ormat Industries Ltd., Retalix Ltd. and as Chairman of Sphera Funds Management Ltd. Mr. Shrem holds a B.A in Economics and Accounting from Bar-Ilan University and an M.B.A. from Tel-Aviv University.
Amitay Weiss
President
Mr. Weiss joined the Company in August 2020. He is founder and Chief Executive Officer of Amitay Weiss Management Ltd. Prior to forming his company, he held several positions at Bank Poalei Agudat Israel Ltd., most recently as Vice President of Business Marketing & Development. He currently chairs and serves as director on the boards of several public companies. Mr. Weiss earned his B.A in Economics from New England College, his M.B.A and LL.B from from Ono Academic College in Israel – a branch of the University of Manchester.
Adi Zuloff-Shani, PhD.
Chief Technologies Officer
Dr. Zuloff-Shani joined the Company in February 2016, bringing more than 20 years of experience as a research and development executive in the bio-tech industry and launching start-ups in the healthcare industry. Dr. Zuloff-Shani brought 2 products from bench to market and is currently leading the development of several pharmaceutical products designated to the US, EU and Israeli markets.
Prior to joining us, she served as Vice President Development at Macrocure Ltd. (Nasdaq: “MCUR”) where she lead all research and development activities. Dr. Zuloff-Shani earned her Ph.D. in Human Biology and Immunology from Bar- Ilan University, Israel.
Oz Adler, CPA
Chief Financial Officer and Chief Executive Officer
Mr. Adler joined the Company in September 2017, and since April 2018 serves as the Company Chief Financial Officer .Mr. Adler has a wide variety of managerial, financial, tax and accounting experience. Prior to joining the Company, Mr. Adler was employed as a CPA at Kost Forer Gabbay & Kasierer, a member of Ernst & Young Global. He currently chairs and serves as director on the boards of several private and public companies. Mr. Adler holds a B.A. in Accounting and Business Management from The College of Management, Israel.